Best Peptide for Muscle Repair & Myogenesis Research
TB-500 dominates muscle repair and myogenesis research through its actin cytoskeleton regulation, satellite cell migration promotion, and anti-inflammatory signaling in muscle injury models. The Thymosin Beta-4 fragment is the established standard for skeletal muscle regeneration studies.
TOP RECOMMENDATION
TB-500 — Thymosin Beta-4 Fragment (17-23)
TB-500 is the leading peptide for muscle repair and myogenesis research. Its actin cytoskeleton regulation directly controls myoblast migration, satellite cell activation, and myotube fusion — the core biological processes of skeletal muscle regeneration. Published studies demonstrate TB-500 upregulates myogenic regulatory factors (MyoD, myogenin) in C2C12 cultures, promotes satellite cell migration to injury sites, and reduces inflammatory cytokine damage in muscle trauma models. BPC-157 contributes through growth hormone receptor upregulation and nitric oxide-mediated vasodilation, which benefits nutrient delivery to regenerating tissue. However, for direct myogenesis, satellite cell behavior, and muscle regeneration readouts, TB-500's actin mechanism provides the mechanistic precision that defines the field.
WHY IT WINS
- Regulates actin cytoskeleton dynamics in myoblasts and satellite cells, controlling migration, fusion, and differentiation during muscle regeneration
- Promotes satellite cell migration to injury sites in skeletal muscle trauma models, accelerating myofiber regeneration
- Downregulates TNF-α and IL-6 in damaged muscle tissue, reducing secondary inflammatory damage and fibrosis
- Upregulates myogenic regulatory factors (MyoD, myogenin) in C2C12 and primary myoblast cultures
- Systemic distribution enables whole-muscle regeneration research without requiring localized injection into specific muscle groups
APPLICATION SUITABILITY MATRIX
| RESEARCH APPLICATION | TB-500 | BPC-157 |
|---|---|---|
| Myoblast Proliferation | ||
| Satellite Cell Migration | ||
| Myotube Fusion | ||
| MyoD / Myogenin Expression | ||
| Anti-Inflammatory in Muscle | ||
| Muscle Fibrosis Reduction | ||
| Vascularization of Muscle | ||
| Stability in Long Studies |
IDEAL RESEARCH APPLICATIONS
- C2C12 myoblast proliferation and differentiation assays
- Satellite cell migration and activation studies
- Skeletal muscle injury and regeneration models
- Muscle fibrosis and anti-inflammatory research
- Myogenic regulatory factor expression (MyoD, myogenin)
ALTERNATIVE: BPC-157
RUNNER-UP
BPC-157 — Body Protection Compound-157
Consider when:
- Growth hormone receptor upregulation and NO synthesis enhancement provide an alternative muscle repair mechanism through vasculature and nutrient delivery
- Superior stability and lower cost make BPC-157 attractive for high-throughput myoblast screening where actin dynamics are not the primary readout
- Consider in combination with TB-500 for studies targeting both satellite cell migration (TB-500) and local growth factor signaling (BPC-157)
ANALYTICAL SPECIFICATIONS
Compound
Thymosin Beta-4 Fragment (17-23)
CAS Number
77591-33-4
Purity (HPLC)
≥ 98.8%
Molecular Weight
4,963.5 g/mol
Sequence
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Trp-Ser-Gln-Glu-Arg-Glu-Arg-Gln-Glu-Lys-Asn-Glu
Verification
HPLC + MS per batch
FREQUENTLY ASKED QUESTIONS
Why is TB-500 better than BPC-157 for muscle repair research?
TB-500 regulates the actin cytoskeleton, which controls myoblast migration, satellite cell activation, and myotube fusion — the core processes of muscle regeneration. BPC-157 contributes through growth factor upregulation and vasodilation but lacks the direct actin-mediated cell motility mechanism that drives myogenesis.
What concentration of TB-500 should I use in C2C12 myoblast studies?
For C2C12 myoblast proliferation and differentiation assays, TB-500 is typically evaluated at 1–25 mcg/ml in differentiation media (2% horse serum). MyoD and myogenin expression are assessed by Western blot or qPCR at 24–72 hours. Myotube fusion index is quantified by phase-contrast microscopy at 96 hours.
Does TB-500 reduce muscle fibrosis after injury?
Research indicates TB-500 reduces collagen deposition and fibrosis in skeletal muscle injury models by downregulating TGF-β1 and promoting proper matrix remodeling. This anti-fibrotic effect is attributed to its anti-inflammatory cytokine modulation and MMP regulation.
Can TB-500 be studied in dystrophic muscle models?
Yes. TB-500 has been evaluated in mdx mouse models of Duchenne muscular dystrophy. Its promotion of satellite cell function and reduction of inflammatory damage addresses two key pathological features of muscular dystrophy: impaired regeneration and chronic inflammation.
How does TB-500 affect muscle vascularization?
TB-500 promotes angiogenesis in muscle tissue through endothelial cell migration and VEGF upregulation. Improved vascularization enhances oxygen and nutrient delivery to regenerating myofibers. This vascular effect is complementary to its direct myogenic signaling.
REFERENCES
- [1]Evans, M. et al. (2013). The regenerative peptide TB-500. Journal of Experimental & Integrative Medicine, 3(4), 287–290.
- [2]Goldstein, A.L. et al. (2012). Thymosins in health and disease. Annals of the New York Academy of Sciences, 1269(1), 1–4.
- [3]Malinda, K.M. et al. (2008). Thymosin beta4 promotes wound repair. Annals of the New York Academy of Sciences, 1112(1), 117–125.
- [4]Qiu, P. et al. (2011). Thymosin beta4 accelerates wound healing. Journal of Investigative Dermatology, 131(5), 1117–1125.
TOP RECOMMENDATION
TB-500
Thymosin Beta-4 Fragment (17-23)
QUICK LINKS
RELATED RESEARCH GOALS
RESEARCH USE ONLY. All compounds are strictly for in-vitro laboratory research by qualified professionals. Not for human consumption, veterinary use, or clinical application.